Join the Carboplatin group to help and get support from people like you.
Carboplatin News
Cancer Drug Shortages Persist Across U.S.
THURSDAY, Oct. 5, 2023 – U.S. cancer centers continue to have shortages of commonly used chemotherapy drugs, a new survey shows, though the medications are not as scarce as they were last June. The...
FDA Medwatch Alert: Injectable Products by Mylan: Recall - Presence of Particulate Matter
including certain lots of: Gemcitabine for Injection Carboplatin Injection Methotrexate Injection Cytarabine Injection See the press release for a listing of the product strength, NDC, and lot...
FDA Medwatch Alert: Carboplatin Injection by Hospira: Recall - Visible Particulate Matter Identified
ISSUE: Hospira, Inc. is further informing the general public about a previously communicated voluntary user-level recall of three lots of Carboplatin Injection due to visible particulates identified...
FDA Medwatch Alert: Hospira Injectable Drug Products: Recall - Visible Particulates from Defective Glass Vials
Including certain lots of the following products: carboplatin cytarabine paclitaxel methotrexate [Posted 07/16/2012] ISSUE: Hospira and FDA notified healthcare professional of a nationwide recall...